An interview with Dr. Sharon Giordano, co-chair on "Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update." Dr. Giordano discusses the results and impact of the monarchE trial, the updated recommendations on the use of abemaciclib, and impact for clinicians and patients. For more information, visit www.asco.org/breast-cancer-guidelines.
View all episodes
By American Society of Clinical Oncology (ASCO)
4.6
4444 ratings
An interview with Dr. Sharon Giordano, co-chair on "Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update." Dr. Giordano discusses the results and impact of the monarchE trial, the updated recommendations on the use of abemaciclib, and impact for clinicians and patients. For more information, visit www.asco.org/breast-cancer-guidelines.
317 Listeners
497 Listeners
40 Listeners
68 Listeners
17 Listeners
58 Listeners
187 Listeners
33 Listeners
22 Listeners
368 Listeners
228 Listeners
57 Listeners
192 Listeners
44 Listeners
3 Listeners